Have any questions? 706-721-6582 or cts@augusta.edu
| Study Name | Principal Investigator |
|---|---|
| BeiGene, Ltd. / “A Phase 1/2, Open-Label, Dose-Escalation and -Expansion Study of the Bruton Tyrosine Kinase-Targeted Protein-Degrader BGB-16673 in Patients With B-Cell Malignancies | Bryan, Locke |
RESEARCH. INNOVATION. DISCOVERY.